Three companies reported on the same day, October 22, 2026, and their finance chiefs described very different businesses. At Lam Research, which makes equipment for chip factories, demand is running ahead of what the supply chain can deliver. At Dow and Union Pacific, management is mostly defending profit by cutting costs and raising prices against expensive energy and fuel. A caution on sourcing: the call summaries behind this piece come from a feed whose claims held up 60% of the time across 1,107 checked claims.1 We therefore anchor the analysis on SEC-checked Dow figures and on direct quotes from named executives.
Lam Research: the constraint is supply, not demand
Lam's CEO, Timothy Archer, said the September quarter set records, with operating margin topping 40% for the first time. He put the preliminary 2027 outlook for wafer fab equipment (the machinery chipmakers buy to build factories) at more than $200 billion of spending, led by DRAM memory.2
The most useful line came from CFO Douglas Bettinger on the December-quarter guide. He said: "We're expecting revenue of $8.6 billion, plus or minus $400 million."2 He then added: "This revenue guide would have been a bit higher, if not for some near-term supply chain constraints that we are actively managing."2 When asked how large unconstrained 2027 demand might be, he declined to give a figure: "I'm not going to put a number on what the unconstrained demand would be."2 The call summary says 2027 is expected to be higher.2
For an ordinary investor, the point is who is limiting growth. Lam's customers want more than it can ship, and Lam itself is the one saying so. That is a better position than needing to chase orders. It is not a guarantee, though: Lam gave no number for the shortfall, and neither do we.
Dow: self-help against a backdrop that isn't helping
Dow's numbers explain why its management talks about cost cutting. Verified SEC filings show revenue sliding from $44.6 billion in fiscal 2023 to $43.0 billion in 2024 and $40.0 billion in 2025.3 Earnings per share went from $0.82 to $1.57 and then to a loss of $3.70 per share in 2025.3 Cash generated by operations fell from $5.2 billion to $2.9 billion and then to $1.0 billion over the same three years.3
Costs did not fall as fast as sales. Cost of revenue was $37.4 billion in 2025 against $40.0 billion of revenue,3 which leaves about $2.5 billion (our arithmetic) to cover every other expense. That is a thin cushion for a company with roughly 718 million shares outstanding.3
Against that history, the third quarter reads as a turn. Dow's CEO, Karen Carter, said net sales rose 13% year over year with growth in every operating segment, and operating EBITDA was more than $1.5 billion.1 She said the "Transform to Outperform" programme was on track for about $700 million of improvements this year and includes cutting approximately 4,500 Dow roles, about 70% of which are already implemented.1 CFO Jeffrey Tate said: "our SARD was actually down $130 million", referring to selling, general and administrative costs.1 He also said Dow is committed to "approximately $1.3 billion in net benefits this year as well as $1.3 billion in 2027".1
Tate was candid that the outside world is not helping: "Persistently high energy costs continue to challenge industry economics."1 For the fourth quarter he said seasonality should be "largely offset by more than $100 million of lower sequential turnaround spending", and he expects global polyethylene margins to improve by roughly $0.02 per pound.1 These are small, mechanical improvements, which is what self-help looks like.
The balance sheet is the cushion
Tate reported third-quarter free cash flow of $1.1 billion. He said: "We have approximately $14 billion of liquidity and no substantive debt maturities until 2029."1 To put $14 billion in scale, it is about a third of Dow's entire 2025 sales of $40.0 billion.3 The summary also cites a working-capital improvement of about $1.3 billion and a 2027 cash conversion target of 70% to 80%.1
Verified balance-sheet cash tells a more cautious story than the liquidity figure. Dow held $3.8 billion at the end of fiscal 2025, $4.6 billion at the end of Q3 2025 and $4.1 billion in Q1 2026.3 The headline $14 billion therefore includes more than cash on hand, and we cannot break it down from this dossier. Readers should treat it as management's definition, not an audited figure.
Union Pacific: fuel is the swing factor
Union Pacific reported record results. Net income was $2.1 billion and adjusted earnings per share rose 15% to $3.53 on 6% volume growth, according to CEO Vincenzo Vena, who also said "Higher fuel prices were a big cost driver."4 CFO Jennifer Hamann put numbers on that: "Fuel expense grew 69% on a 64% increase in average fuel price."4 The call summary puts the average price at $2.56 per gallon rising to $4.21.4
The company still affirmed high single-digit growth in 2026 reported EPS and lifted 2026 capital spending to $3.5 billion.4 Hamann also said: "We will continue growing our cash reserves in anticipation of closing the Norfolk Southern merger in the second half of 2027."4 Union Pacific is therefore holding cash for a deal while fuel costs bite, a balance-sheet decision more than an operating one.
How the two halves connect
Our reading, which is our analysis and not a company statement, is that the two halves are linked through the dossier's entity graph. Lam supplies hyperscalers, the large cloud companies, and competes with ASML and Applied Materials. Dow develops a packaging resin used in advanced packaging, a field where Lam also develops technology. We would not stretch that into a causal claim. It does show that the AI buildout and a commodity chemicals maker touch the same supply chain.
The takeaway for a saver with an index fund is about what each company controls. Lam is limited by capacity it must build. Dow and Union Pacific are limited by input prices they cannot set, so they work on what they can: headcount, overheads, pricing and cash. The dossier does not tell us how much of any of these companies sits in a given index fund, so we make no claim on that.
What to watch
- Lam's supply constraints. Whether the revenue it said it would have booked shows up in later quarters, and whether it ever quantifies unconstrained 2027 demand.
- Dow's fourth quarter. The summary headline points to about $1.5 billion of EBITDA, and the test is whether the $1.3 billion of 2027 self-help benefits arrives on schedule.1
- Union Pacific's fuel bill and cash build ahead of the Norfolk Southern merger expected to close in the second half of 2027.4
- The FDA's decision date for Summit Therapeutics' ivonescimab, a target of November 14, 2026.5
Smaller items in this season's commentary include the Durbin Amendment's effect on Origin Bancorp and CFO turnover at Rivian and Union Pacific. The dossier has too little verified detail on them for us to analyse here.
